Search research articles
Contact Us
Filters
Showing results (421-430 of 465) with videos related to
Page
of 47
Sort By:
Journal of the National Cancer Institute
|
June 6, 2019
The Trials (and Tribulations) of Complementary and Alternative Medicine in Oncology
Ethan B Ludmir, Amit Jethanandani, Walker Mainwaring, et al.
Cancers
|
September 19, 2020
Trial Sponsorship and Time to Reporting for Phase 3 Randomized Cancer Clinical Trials
Timothy A Lin, Clifton David Fuller, Vivek Verma, et al.
The Lancet. Oncology
|
October 1, 2013
Abiraterone acetate plus prednisone versus prednisone alone in chemotherapy-naive men with metastatic castration-resistant prostate cancer: patient-reported outcome results of a randomised phase 3 trial
Ethan Basch, Karen Autio, Charles J Ryan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 28, 2019
Apalutamide and overall survival in non-metastatic castration-resistant prostate cancer
E J Small, F Saad, S Chowdhury, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 16, 2008
Two different first-line 5-fluorouracil regimens with or without oxaliplatin in patients with metastatic colorectal cancer
D Cunningham, B Sirohi, A Pluzanska, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
January 27, 2026
Rapid Decentralized Prostate Cancer Risk Stratification by Portable Liquid Biopsy Analysis within a Clinical Biosensor Validation Framework
Kevin M Koo, Grant Phillips, Sriganesh Srihari, et al.
ACS Applied Materials & Interfaces
|
August 6, 2016
"Race for the Surface": Eukaryotic Cells Can Win
Vy T H Pham, Vi Khanh Truong, Anna Orlowska, et al.
Mayo Clinic Proceedings
|
February 7, 2021
Detecting the Dark Matter of Unpublished Clinical Cancer Studies: An Analysis of Phase 3 Randomized Controlled Trials
Dario Pasalic, C David Fuller, Walker Mainwaring, et al.
Leukemia & Lymphoma
|
August 1, 2002
Treatment of refractory acute leukemia with timed sequential chemotherapy using topotecan followed by etoposide + mitoxantrone (T-EM) and correlation with topoisomerase II levels
M G Mainwaring, L M Rimsza, S F Chen, et al.
Nature Communications
|
March 3, 2023
ARF suppression by MYC but not MYCN confers increased malignancy of aggressive pediatric brain tumors
Oliver J Mainwaring, Holger Weishaupt, Miao Zhao, et al.
Page
of 47
Search research articles
Search
Showing results (421-430 of 465) with videos related to
Sort By:
Page
of 47
Journal of the National Cancer Institute
|
June 6, 2019
The Trials (and Tribulations) of Complementary and Alternative Medicine in Oncology
Ethan B Ludmir, Amit Jethanandani, Walker Mainwaring, et al.
Cancers
|
September 19, 2020
Trial Sponsorship and Time to Reporting for Phase 3 Randomized Cancer Clinical Trials
Timothy A Lin, Clifton David Fuller, Vivek Verma, et al.
The Lancet. Oncology
|
October 1, 2013
Abiraterone acetate plus prednisone versus prednisone alone in chemotherapy-naive men with metastatic castration-resistant prostate cancer: patient-reported outcome results of a randomised phase 3 trial
Ethan Basch, Karen Autio, Charles J Ryan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 28, 2019
Apalutamide and overall survival in non-metastatic castration-resistant prostate cancer
E J Small, F Saad, S Chowdhury, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 16, 2008
Two different first-line 5-fluorouracil regimens with or without oxaliplatin in patients with metastatic colorectal cancer
D Cunningham, B Sirohi, A Pluzanska, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
January 27, 2026
Rapid Decentralized Prostate Cancer Risk Stratification by Portable Liquid Biopsy Analysis within a Clinical Biosensor Validation Framework
Kevin M Koo, Grant Phillips, Sriganesh Srihari, et al.
ACS Applied Materials & Interfaces
|
August 6, 2016
"Race for the Surface": Eukaryotic Cells Can Win
Vy T H Pham, Vi Khanh Truong, Anna Orlowska, et al.
Mayo Clinic Proceedings
|
February 7, 2021
Detecting the Dark Matter of Unpublished Clinical Cancer Studies: An Analysis of Phase 3 Randomized Controlled Trials
Dario Pasalic, C David Fuller, Walker Mainwaring, et al.
Leukemia & Lymphoma
|
August 1, 2002
Treatment of refractory acute leukemia with timed sequential chemotherapy using topotecan followed by etoposide + mitoxantrone (T-EM) and correlation with topoisomerase II levels
M G Mainwaring, L M Rimsza, S F Chen, et al.
Nature Communications
|
March 3, 2023
ARF suppression by MYC but not MYCN confers increased malignancy of aggressive pediatric brain tumors
Oliver J Mainwaring, Holger Weishaupt, Miao Zhao, et al.
Page
of 47